Secondaries announced 7.21.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Dynavax
Symbol: DVAX
Price: Last trade $27.80
Trade Date: 7/22
Shares: 3.6 million
Underwriter(s) Cowen, RBC, William Blair
Rating=Subscription Needed

Company: Exelixis
Symbol: EXEL
Price: Last trade $6.06
Trade Date: 7/22
Shares: 20 million
Underwriter(s) Cowen & Co., William Blair, Stifel
Rating=Subscription Needed

Company: Fibrocell Science
Symbol: FCSC
Price: Last trade $5.87
Trade Date: 7/22
Shares: TBD
Underwriter(s) Wells Fargo Securities
Co Manager(s) Roth Capital Partners, Griffin Securities
Rating=Subscription Needed

Company: Radius Health, Inc.
Symbol: RDUS
Price: Last trade $78.29
Trade Date: 7/23
Shares: 3.2 million
Underwriter(s) J.P. Morgan, BofA Merrill Lynch, Deutsche Bank Securities, Cowen & Co.
Rating=Subscription Needed

Company: Pattern Energy Group Inc.
Symbol: PEGI
Price: Last trade $25.74
Trade Date: 7/23
Shares: 4.9 million
Underwriter(s) BMO, BofA Merrill Lynch, Citigroup
Rating=Subscription Needed

Company: Seritage Growth Properties-BLOCK
Symbol: SRG
Price: Last trade $40.38
Trade Date: 7/22
Shares: 1.45 million
Underwriter(s) Morgan Stanley
Rating=Subscription Needed

Company: Regulus Therapeutics Inc.-BLOCK
Symbol: RGLS
Price: Last trade $10.21
Trade Date: 7/22
Shares: 2.33 million
Underwriter(s) UBS
Rating=Subscription Needed